ECP-1014 Treatment for Patients With Solid Tumor Cancers
NCT04930354
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
29
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Interventions
DRUG:
ECP-1014
Sponsor
Euclises Pharmaceuticals, Inc.